Critical gases for critical issues: CO₂ technologies for oral drug delivery

Papers of special note have been highlighted as: ▪ of interest

References

• 1  European Environmental Agency. Pharmaceuticals in the environment. Results of an EEA workshop. Technical report No 1 /2010. European Environmental Agency. Copenhagen, Denmark, 1725–2237 (2010).
  Google Scholar
• 2  European Medicines Agency. Road map to 2015. The European Medicines Agency‘s contribution to science, medicines and health. European Medicine Agency. Adopted by the Agency‘s Management Board on December 2010. European Medicines Agency. London, UK (2011).
  Google Scholar
• 3  Department of Health and Human Services, US Food and Drug Administration. Innovation, Stagnation, Challenge and Opportunity on the Critical Path to New Medical Products. Silver Spring, MD, USA (2004).
  Google Scholar
• 4  Department of Health and Human Services, US Food and Drug Administration. Pharmaceutical Development Q8 (R2). ICH Harmonized Tripartite Guidelines. Current Step 4 Version. ICH Expert Working Group. Geneva, Switzerland (2009).
  Google Scholar
• 5  Yu LX. Pharmaceutical quality by design: product and process development, understanding, and control. Pharm. Res.25(4),781–791 (2008).
  Medline CASGoogle Scholar
• 6  Bossart J, Sedo K, Kararli TT. Delivery report drug delivery products & technologies, a decade in review: approved products 2000 to 2009. Drug Deliv. Technol.10(4),28–31(2010).
  Google Scholar
• 7  BCC Research. Advanced Drug Delivery Systems: Technologies and Global Markets. BCC Research Pharmaceutical Report, Market Forecasting. Wellesley, MA, USA (2011).
  Google Scholar
• 8  Stegemann S, Klebovich I, Antal I et al. Improved therapeutic entities derived from known generics as an unexplored source of innovative drug products. Eur. J. Pharm. Sci.44,447–454 (2011).▪ Highlights the importance and impact of innovative formulation and process technologies in future development of known drug products.
  Medline CASGoogle Scholar
• 9  Eickenbaum G. Chair‘s Opening Address. Presented at: Pharma IQ conference on Improving Solubility 09. Thistle Marble Arch, London, UK, 29 June–1 July 2009.
  Google Scholar
• 10  Stegemann S. Design Drug Delivery for individual patient populations. Presented at: The 5th Annual Drug Delivery Systems conference. London, UK, 10–11 February 2010.
  Google Scholar
• 11  Stegemann S, Ecker F, Maio M et al. Geriatric drug therapy: neglecting the inevitable majority. Aging Res. Rev.9,384–398 (2010).
  MedlineGoogle Scholar
• 12  Girotra P, Singh SK, Nagpal K. Supercritical fluid technology: a promising approach in pharmaceutical research. Pharm. Dev. Technol.18(1),22–38 (2013).
  Medline CASGoogle Scholar
• 13  Zarena AS, Sankar KU. Design of submicron and nanoparticle delivery using supercritical carbon dioxide-mediated processes: an overview. Ther. Deliv.2(2),259–277 (2011).
  CASGoogle Scholar
• 14  Bettini R. Microparticles by supercritical fluids technologies: myth, challenge or reality? Presented at: The 18th International Symposium on Microencapsulation. Antalya, Turkey, 12–14 September 2011.
  Google Scholar
• 15  Pasquali I, Bettini R. Are pharmaceutics really going supercritical? Int. J. Pharm.364,176–187 (2008).▪ Critical review on actual applicability and perspectives of supercritical fluid (SCF) technologies in the pharmaceutical industry.
  Medline CASGoogle Scholar
• 16  Jessop PG, Subramanian B. Gas-expanded liquids. Chem. Rev.107,2666–2694 (2007).▪ Complete review on the basic principles and application of dense gases. Discusses the consequences of CO2 expansion and properties changes.
  Medline CASGoogle Scholar
• 17  Foster N, Mammucari R, Dehgani F, Barrett A, Bezanehtak K, Coen E. Processing pharmaceutical compounds using dense gas technology. Ind. Eng. Res.42,6476–6493 (2003).▪ Introductory concepts on dense gases, supercritical and subcritical.
  CASGoogle Scholar
• 18  Dobbs JM, Wong JM, Johnston KP. Nonpolar co-solvent for solubility enhancement in supercritical fluid carbon dioxide. J. Chem. Eng. Data31,303–308 (1986).
  CASGoogle Scholar
• 19  Beckman EJ. Supercritical and near critical CO₂ in green chemical synthesis and processing. J. Supercrit. Fluids28,121–191 (2004).
  CASGoogle Scholar
• 20  Tabernero A, Martín del Valle EM, Galán MA. Supercritical fluids for pharmaceutical particle engineering: methods, basic fundamentals and modelling. Chem. Eng. Process.60,9–25 (2012).▪ Compendium of SCF processes for pharmaceutical particles, with relevant information on process modelling.
  CASGoogle Scholar
• 21  Carr AG, Mammucari R, Foster NR. A review of subcritical water as a solvent and its utilization for the processing of hydrophobic organic compounds. Chem. Eng. J.172,1–17 (2011).
  CASGoogle Scholar
• 22  Carr AG, Mammucari R, Foster NR. Particle formation of budesonide from alcohol-modified subcritical water solutions. Int. J. Pharm.405,169–180 (2011).
  Medline CASGoogle Scholar
• 23  Hao J, Whitaker MJ, Wong B, Serhatkulu G, Shakesheff KM, Howdle SM. Plasticization and spraying of poly(dl-lactic acid) using supercritical carbon dioxide: control of particle size. J. Pharm. Sci.93(4),1083–1090 (2004).
  Medline CASGoogle Scholar
• 24  Jimenénez A, Thompson GL, Mathews MA et al. Compatibility of medical-grade polymers with dense CO₂. J. Supercrit. Fluids42,366–372 (2007).
  MedlineGoogle Scholar
• 25  Tian J, Thallapally PK, Dalgarno SJ, Atwood JL. Free transport of water and CO₂ in nonporous hydrophobic clarithromycin form II Crystals. J. Am. Chem. Soc.131,13216–13217 (2009).
  Medline CASGoogle Scholar
• 26  Kikic I, Vecchione F. Supercritical impregnation of polymers. Curr. Opin. Solid State Mater. Sci.7,399–405 (2003).
  CASGoogle Scholar
• 27  Üzer S, Akman U, Hortaçsu Ö. Polymer swelling and impregnation using supercritical CO₂: A model-component study towards producing controlled-released drugs. J. Supercrit. Fluids38,119–128 (2006).
  CASGoogle Scholar
• 28  Natu MV, Gil MH, de Sousa HC. Supercritical solvent impregnation of poly(ε-caprolactone)/poly(oxyethylene-b-oxypropylene-b-oxyethylene) and poly(ε-caprolactone)/poly(ethylene-vinyl acetate) blends for controlled release applications. J. Supercrit. Fluids47(2008) 47,93–102 (2008).
  CASGoogle Scholar
• 29  Banchero M, Manna L, Ronchetti S, Campanelli P, Ferri A. Supercritical solvent impregnation of piroxicam on PVP at various polymer molecular weight. J. Supercrit. Fluids49,271–278 (2009).
  CASGoogle Scholar
• 30  Yasuji T, Takeuchi H, Kawashima Y. Particle design of poorly water-soluble drug substances using supercritical fluid technologies. Adv. Drug Deliv. Rev.60,388–398 (2008).▪ Compendium about SCF properties relevant for poorly water soluble molecules, and application in particle formation.
  Medline CASGoogle Scholar
• 31  Türk M, Crone M, Kraska T. A comparison between models based on equations of state and density-based models for describing the solubility of solutes in CO₂. J. Supercrit. Fluids55,462–471 (2010).
  CASGoogle Scholar
• 32  Riviera CA, Khalloufi S, Jansen J, Bongers P. Mathematical Description of Mass Transfer in Supercritical-Carbon-Dioxide-Drying Process. Proceedings of the 21st European Symposium on Computer Aided Process Engineering-ESCAPE 2. Pistikopoulos EN, Georgiadis MC, Kokossis AC (Eds). Elsevier, Amsterdam, The Netherlands, 36–40 (2011).
  Google Scholar
• 33  Bouchard A, Jocanovic N, Hofland GW, Mendes E, Crommelin DJA, Witkamp GJ. Supercritical fluid drying carbohydrates: SELECTION of suitable excipients and process conditions. Eur. J. Pharm. Biopharm.68(3),781–794 (2008).
  Medline CASGoogle Scholar
• 34  Cansell F, Aymonier C, Serani AL. Review on material science and supercritical fluids. Curr. Opin. Solid State Mater. Sci.7(4–5),331–340 (2003).
  CASGoogle Scholar
• 35  Rodier E, Lochard H, Sauceau M, Letoumeau JJ, Freiss B, Fages J. A three step supercritical process to improve the dissolution rate of Eflucimibe. Eur. J. Pharm. Sci.26(2),184–193 (2005).
  Medline CASGoogle Scholar
• 36  Lee MY, Ganapathy HS, Lim KT. Controlled drug release applications of the inclusion complex of percetylated-β-cyclodextrin and water-soluble drugs formed in supercritical carbon dioxide. J. Phys. Chem. Solids71,630–633 (2010).
  CASGoogle Scholar
• 37  Sultana T, Jung JM, Hong SS et al. Characteristic profiles of the inclusion complex of omeprazole/peracylated-β-cyclodextrin formed in supercritical carbon dioxide. J. Incl. Phenom. Macrocycl. Chem.72,207–212 (2012).
  CASGoogle Scholar
• 38  Ugaonkar S, Nunes AC, Needham TE. Effect of n-sc-CO₂ on crystalline to amorphous conversion of carbamazepine. Int. J. Pharm.333,152–161 (2007).
  Medline CASGoogle Scholar
• 39  Tian J, Dalgarno SJ, Atwood JL. A new strategy of transforming pharmaceutical crystal forms. J. Am. Soc.133,1399–1404 (2011).▪ Description of CO2-induced transformations of crystal structures controlled by different pressure and temperature conditions.
  CASGoogle Scholar
• 40  Shan N, Zaworothko MJ. The role of cocrystals in pharmaceutical science. Drug Discov. Today13(9/10),440–446 (2008).
  Medline CASGoogle Scholar
• 41  Schultheiss N, Newman A. Pharmaceutical cocrystals and their physicochemical properties. Cryst. Growth Des.9(6),2950–2967 (2009).
  Medline CASGoogle Scholar
• 42  US Department of Health and Human Services, FDA, CDER. Guidance for Industry, Regulatory Classification of Pharmaceutical Co-Crystals. US Department of Health and Human Services, FDA, CDER. Silverspring, MD, USA (2011).
  Google Scholar
• 43  Padrela L, Rodrigues MA, Velga SP, Matos HA, de Azevedo EG. Formation of indomethacin-saccharin cocrystals using supercritical fluid technology. Eur. J. Pharm. Sci.38(1),9–17 (2009).
  Medline CASGoogle Scholar
• 44  Padrela L, Rodrigues MA, Velga SP, Fernandes AC, Matos HA, de Azevedo EG. Screening for pharmaceutical cocrystals using the supercritical fluid enhanced atomization process. J. Supercrit. Fluids53(1–3),156–164 (2010).
  CASGoogle Scholar
• 45  Sekhon BS. Supercritical fluid technology: an overview of pharmaceutical applications. Int. J. Pharm Tech Res.2(1),810–826 (2010).▪ Complete review on SCF technology in pharmaceutics.
  CASGoogle Scholar
• 46  Martin del Valle EM, Galan MA. Supercritical fluid technique for particle engineering: drug delivery applications. Rev. Chem. Eng.21(1),33–69 (2005).▪ Overview of technologies including considerations on scale-up and industrial costs of SCF technique processes.
  Google Scholar
• 47  Quirk RA, France RM, Shakesheff KM, Howdle SM. Supercritical fluid technologies and tissue engineering scaffolds. Curr. Opin. Solid State Mater. Sci.8(3–4),313–321 (2004).
  CASGoogle Scholar
• 48  Cardea S, Pisanti P, Reverchon E. Generation of chitosan nanoporous structures for tissue engineering applications using a supercritical fluid assisted process. J. Supercrit. Fluids45(3),290–295 (2010).
  Google Scholar
• 49  Martín Á, Weidner E. PGSS-drying: mechanism and modelling. J. Supercrit. Fluids55,271–281 (2010).▪ Provides good understanding of the basics of PGSS drying mechanism, and its implications for particles formation.
  CASGoogle Scholar
• 50  Meterc D, Petermann M, Weinder E. Drying of aqueous green tea extracts using a supercritical fluid process. J. Supercrit. Fluids45,253–259 (2008).
  CASGoogle Scholar
• 51  Martín Á, Pham HM, Kilzer A, Kareth S, Weinder E. Micronization of polyethylene glycol by PGSS (Particles from Gas Saturated Solutions)-drying of aqueous solutions. Chem. Eng. Process.49,1259–1266 (2010).
  CASGoogle Scholar
• 52  Vezzù K, Borin D, Bertucco A, Bersani S, Salmaso S, Caliceti P. Produciton of lipid microparticles containing bioactive molecules functionalized with PEG. J. Supercrit. Fluids54,328–334 (2010).
  CASGoogle Scholar
• 53  Salmaso S, Elvassore N, Bertucco A, Caliceti P. Production of solid lipid submicron particles for protein delivery using a novel supercritical gas-assisted melting atomization. J. Pharm. Sci.98(2),640–650 (2009).
  Medline CASGoogle Scholar
• 54  Reverchon E, Adami R, Caputo G, de Marco I. Spherical microparticles production by supercritical antisolvent precipitation: interpretation of results. J. Supercrit. Fluids47,70–84 (2008).▪ Compendium of microparticle systems produced by supercritical antisolvent, rationalization of results and data interpretation.
  CASGoogle Scholar
• 55  Tropainen T, Velga S, Heikkilä T, Matilainen L, Jarho P, Carlfors J. Preparation of budesonide/γ-cyclodextrin complexes in supercritical fluids with a novel SEDS method. J. Pharm. Sci.95(10),2235–2245 (2006).
  MedlineGoogle Scholar
• 56  Thote AJ, Gupta RB. Formation of nanoparticles of hydrophilic drug using supercritical CO₂ and microencapsulation for sustained release. NSTI-Nanotech.1,116–119 (2005).
  CASGoogle Scholar
• 57  Ventosa N, Veciana J, Sala S, Myntó M, Cano M, Gimeno M. New technologies for the preparation of micro-and nanostructured materials with potential applications in drug delivery and clinical diagnostics. Contrib. Sci.3(1),11–18 (2005).
  Google Scholar
• 58  Sievers RE, Huang ETS, Villa JA, Engling G, Brauer PR. Micronizaiton of water-soluble or alcohol-soluble pharmaceuticals and model compounds with a low temperature Bubble Dryer^®. J. Supercrit. Fluids26(1),9–16 (2003).
  CASGoogle Scholar
• 59  Cape SP, Villa JA, Huang ETS, Yang TH, Carpenter JF, Sievers RE. Preparation of active proteins, vaccines and pharmaceuticals as fine powders using supercritical or near-critical fluids. Pharm. Res.25(9),1967–1990 (2008).
  Medline CASGoogle Scholar
• 60  Reverchon E, Antonacci A. Polymer microparticles production by supercritical assisted atomization. J. Supercrit. Fluids39,444–452 (2007).
  CASGoogle Scholar
• 61  Pathak P, Prasad GL, Meziani MJ, Joudeh AA, Sun YP. Nanosized paclitaxel particles from supercritical carbon dioxide processing and their biological evaluation. Langmuir23(5),2674–2679 (2007).
  Medline CASGoogle Scholar
• 62  Sane A, Limtrakul J. Formation of retinyl palmitate-loaded poly (l-lactide) nanoparticles using rapid expansion of supercritical solutions into liquid solvent (RESOLV). J. Supercrit. Fluids51,230–237 (2009).
  CASGoogle Scholar
• 63  Chattopadhyay P, Huff R, Shekunov BY. Drug encapsulation using supercritical fluid extraction of emulsions. J. Pharm. Sci.95(3),667–679 (2006).
  Medline CASGoogle Scholar
• 64  Kluge J, Fusaro F, Casas N, Mazzotti M, Muhrer G. Production of PLGA micro and nanocomposites by supercritical fluid extraction of emulsions: encapsulation of lyosozyme. J. Supercrit. Fluids50(3),327–335 (2009).
  CASGoogle Scholar
• 65  Henczka M, Baldyga J, Shekunov BY. Modelling of spray-freezing with compressed carbon dioxide. Chem. Eng. Sci.61,2880–2887 (2006).
  CASGoogle Scholar
• 66  Baldyga J, Czarnocki R, Shekunov B, Smith KB. Particle formation in supercritical fluids-Scale-up problem. Chem. Eng. Res. Des.88,331–341 (2010).▪ Discussion of particle formation mechanisms in solution-enhanced dispersion by supercrticial fluids. Modellization at macro and microscale, and nozzle actuation. Provides an understanding of scale-up issues.
  CASGoogle Scholar
• 67  Reverchon E, Adami R, Caputo G. Supercritical assisted atomization: Performance comparison between laboratory and pilot scale. J. Supercrit. Fluids37,298–306 (2006).
  CASGoogle Scholar
• 68  Liu YH, Maruyama H, Matsusaka S. Agglomeration process of dry ice particles produced by expanding liquid carbon dioxide. Adv. Powder Technol.21,652–657 (2010).
  Google Scholar
• 69  Andersson P. Enhancing drug formulation of challenging compounds using supercritical fluid (SCF) technologies. Presented at: The 3rd Annual WTG Drug Delivery and Formulation. Berlin, Germany, 16–18 January 2012.
  Google Scholar
• 70  Ku MS. Use of the Biopharmaceutical classification System in early drug development. AAPS10(1),208–212 (2008).
  Medline CASGoogle Scholar
• 71  Amidon G, Lennernas H, Shah V, Crison JR. A theoretical basis for a biopharmaceutics drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res.12,413–420 (1995).
  Medline CASGoogle Scholar
• 72  Benet L, Broccatelli F, Oprea T. BDDCS Applied to over 900 drugs. AAPS13(4),519–547 (2011).
  Medline CASGoogle Scholar
• 73  Benet L. The role of BCS (Biopharmaceutics Classification System ) and BDDCS (Biopharmaceutics Drug Disposition Classification System) in drug development. J. Pharm. Sci.102(1),34–42 (2013).▪ Discuss the importance of classification system and practical application in development of new and marketed drugs for oral route.
  Medline CASGoogle Scholar
• 74  Dressman JB, Vertzoni M, Goumas K, Reppas C. Estimating drug solubility in the gastrointestinal tract. Adv. Drug Del. Rev.59,591–602 (2007).
  Medline CASGoogle Scholar
• 75  Shono Y, Jantratid E, Dressman JB. Precipitation in the small intestine may play a more important role in the in vivo performance of poorly soluble weak bases in the fasted state: case example nelfinavir. Eur. J. Pharm. Biopharm.79,349–356 (2011).
  Medline CASGoogle Scholar
• 76  Muenster U, Pelzetter C, Backensfeld T et al. Volume to dissolve applied dose (VDAD) and apparent dissolution rate (ADR): tools to predict in vivo bioavailability from orally applied drug suspensions. Eur. J. Pharm. Biopharm.78,522–530 (2011).
  Medline CASGoogle Scholar
• 77  Bhattachar SN, Deschenes LA, Wesley JA. Solubility: it‘s not just for physical chemists. Drug Discov. Today11(21/22),1012–1018 (2006).
  Medline CASGoogle Scholar
• 78  Saal C, Petereit AC. Optimizing solubility: kinetics versus thermodynamic solubility temptations and risks. Eur. J. Pharm. Sci.47,589–595 (2012).
  Medline CASGoogle Scholar
• 79  Martin A, Scholle K, Mattea F, Meterc D, Cocero MJ. Production of polymorphs of ibuprofen sodium by supercritical antisolvent (SAS) precipitation. Cryst. Growth Des.9(5),2504–2511 (2009).
  CASGoogle Scholar
• 80  Davar N, Ghosh S. Oral controlled release-based products for life cycle management. In: Oral Controlled Release Formulation Design and Drug Delivery: Theory to Practice. Wen H, Park K (Eds). John Wiley & Son, Inc, Hoboken, NY, USA, 305–320 (2010).
  Google Scholar
• 81  Chen X, Wen H, Park K. Challenges and new technologies of oral controlled release. In: Oral Controlled Release Formulation Design and Drug Delivery: Theory to Practice. Wen H, Park K (Eds). John Wiley & Son, Inc, Hoboken, NY, USA, 257–277 (2010).
  Google Scholar
• 82  Grassi M, Grassi G, Lapasin R, Colombo I. Drug Dissolution and Partitioning. In: Understanding Drug Release and Absorption Mechanisms, a Physical and Mathematical Approach. CRC Press, MA, USA, 249–331 (2007).
  Google Scholar
• 83  Knez Z, Weinder E. Particles formation and particle design using supercritical fluids. Curr. Opin. Solid State Mater. Sci.7,353–361 (2003).
  Google Scholar
• 84  Pasquali I, Bettini R, Giordano F. Solid-state chemistry and particle engineering with supercritical fluids in pharmaceutics. Eur. J. Pharm. Sci.27,399–310 (2006).▪ Review of SCF processing affecting solid state properties of formulated microparticles.
  Google Scholar
• 85  Moribe K, Tozuka Y, Yamamoto K. Supercritical carbon dioxide processing of active pharmaceutical ingredients for polymorphic control and for complex formation. Adv. Drug Deliv. Rev.60,328–338 (2008).
  Medline CASGoogle Scholar
• 86  de Zordi N, Kikic I, Moneghini M, Solinas D. Piroxicam solid state studies after processing with SAS technique. J. Supercrit. Fluids55,340–347 (2010).
  CASGoogle Scholar
• 87  Meng D, Falconer J, Krauel-Goellner K, Chen J, Farid M, Alany R. Self-built supercritical CO₂ anti-solvent unit design, construction and operation using carbamazepin. AAPS Pharm. Sci. Tech.9(3),944–952 (2008).
  Medline CASGoogle Scholar
• 88  Mandzuka Z, Kenz Z. Influence of temperature and pressure during PGSS™ micronization and storage time on degree of crystallinity and crystal forms of monostearate and tristearate. J. Supercrit. Fluids, 45,102–111 (2008).
  CASGoogle Scholar
• 89  Cocero MJ, Martín A, Mattea F, Varona S. Encapsulation and co-precipitation processes with supercritical fluids: fundamentals and applications. J. Supercrit. Fluids47,546–555 (2009).
  CASGoogle Scholar
• 90  Duarte AR, Sousa Costa M, Simplício AL, Cardoso MM, Duarte C. Preparation of controlled release microspheres using supercritical fluid technology for delivery of anti-inflammatory drugs. Int. J. Pharm.308,168–174 (2006).
  Medline CASGoogle Scholar
• 91  Reverchon E, Lamberti G, Antonacci A. Supercritical fluid assisted production of HPMC composite microparticles. J. Supercrit. Fluids46,185–196 (2008).▪ Describes use of energy-dispersive x-ray spectroscopy microanalysis to characterize drug distribution in drug-polymer microcomposites.
  CASGoogle Scholar
• 92  Elizondo E, Córdoba A, Santiago S, Ventosa N, Veciana J. Preparation of biodegradable poly(methyl vinyl ether-co-maleic anhydride) nanostructured microparticles by precipitation with compressed antisolvent. J. Supercrit. Fluids53,108–114 (2010).
  CASGoogle Scholar
• 93  Belhadj-Ahmed F, Badens E, Llewellyn P, Denoyel R, Charbit G. Impregnation of vitamin E acetate on silica mesoporous phases using supercritical carbon dioxide. J. Supercrit. Fluids51(2),278–286 (2009).
  CASGoogle Scholar
• 94  Varona S, Rodríguez-Rojo S, Martín A, Cocero MJ, Duarte CM. Supercritical impregnation of lavandin (Lavandula hybrid) essential oil in modified starch. J. Supercrit. Fluids58,313–319 (2011).
  CASGoogle Scholar
• 95  Comin LM, Temelli F, Saldaña MD. Impregnation of flax oil pregelatinized corn starch using supercritical CO₂. J. Supercrit. Fluids51,221–228 (2012).
  Google Scholar
• 96  Manna L, Banchero M, Sola D, Ferri A, Ronchetti S, Sicardi S. Impregnation of PVP microparticles with ketoprofen in the presence of supercritical CO₂. J. Supercrit. Fluids42,378–384 (2007).
  CASGoogle Scholar
• 97  López-Periago A, Argemí A, Anderson JM et al. Impregnation of biocompatible polymer aided by supercritical CO₂: evaluation of drug stability and drug-matrix interactions. J. Supercrit. Fluids48,56–63 (2009).
  CASGoogle Scholar
• 98  Miura H, Kanebako M, Shirai H, Nakao H, Inagi T, Terada K. Influence of particle design on oral absorption of poorly water-soluble drug in a silica particle-supercritical fluid system. Chem. Pharm. Bull.59(6),686–691 (2011).
  Medline CASGoogle Scholar
• 99  Ahern R, Crean A, Ryan K. The influence of supercritical carbon dioxide (sc-CO₂) processing conditions on drug loading and physicochemical properties. Int. J. Pharm.439,92–99 (2012).
  Medline CASGoogle Scholar
• 100  Alnaief M, Smirnova I. In situ production of spherical aerogel microparticles. J. Supercrit. Fluids55,1118–1123 (2011).
  CASGoogle Scholar
• 101  García-González CA, Camino-Rey MC, Alnaief M, Zetzl C, Smirnova I. Supercritical drying of aerogels using CO₂: effect of extraction time on the material textural properties. J. Supercrit. Fluids66,297–306 (2012).
  CASGoogle Scholar
• 102  García-González CA, Smirnova I. Use of supercritical fluid technology for the production of tailor-made aerogel particles for delivery systems. J. Supercrit. Fluids79,152–158 (2013).
  CASGoogle Scholar
• 103  García-González CA, Alnaief M, Smirnova I. Polysaccharide-based aerogels promising biodegradable carriers for drug delivery systems. Carbohyd. Polym.86,1425–1438 (2011).
  CASGoogle Scholar
• 104  Griffin B. Advances in lipid-based formulations: overcoming the challenge of low bioavailability for poorly water soluble drug compounds. Am. Pharma. Rev.15(2), (2012).
  Google Scholar
• 105  Prajapati H, Dalrymple D, Serajuddin A. A comparative evaluation of mono-, di- and triglyceride of medium chain fatty acids by lipid/surfactant/water phase diagram, solubility determination and dispersion testing for application in pharmaceutical dosage form development. Pharm. Res.29,285–305 (2012).
  Medline CASGoogle Scholar
• 106  Tan A, Rao S, Prestidge CA. Transforming lipid-based oral drug delivery systems inot solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance. Pharm. Res.30(12),2993–3017 (2013).▪ Compendium on technologies/processes to obtain solid dosage forms from lipid-based delivery systems for oral route.
  Medline CASGoogle Scholar
• 107  Chun Beh C, Mammucari R, Foster NR. Lipid-based drug carrier systems by dense gas technology: a review. Chem. Eng. J.188,1–14 (2012).▪ Compendium on lipid-delivery systems, produced by different dense-gas technologies. Focused mainly on liposomes and nanoparticles.
  Google Scholar
• 108  Berton A, Piel G, Evrard B. Powdered lipid nano and microparticles: produciton and applications. Recent Pat. Drug Deliv. Formul.5,188–200 (2011).
  Medline CASGoogle Scholar
• 109  Calderone M, Rodier E, Lerourneau JJ, Fages J. Solidification of Precirol^® by the expansion of supercritical fluid saturated melt: from the thermodynamic balance towards the crystallization aspect. J. Supercrit. Fluids42,189–199 (2007).▪ Describes physicochemical methodology to understand crystallization processes of lipidic excipients undergoing CO2 expansion.
  CASGoogle Scholar
• 110  Vijayaraghavan M, Stolnik S, Howdle S, Illum L. Suitability of polymer materials for production of pulmonary microparticles using PGSS supercritical fluid technique: thermodynamic behavior of fatty acids, PEGs and PEG-fatty acids. Int. J. Pharm.438,225–231 (2012).
  Medline CASGoogle Scholar
• 111  Vijayaraghavan M, Stolnik S, Howdle S, Illum L. Suitability of polymer materials for production of pulmonary microparticles using PGSS supercritical fluid technique: preparation of microparticles using PEG, Fatty acids and physical or chemical blends of PEG and fatty acids. Int. J. Pharm.441,580–588 (2013).
  Medline CASGoogle Scholar
• 112  Segale L, Giovanelli L, Danan H, Galli L, Pattarino F. Development of metoclopramide microparticles using Variosol^® technology. Control. Release Newsl.25(3),16–17 (2008).
  Google Scholar
• 113  Segale L, Mannina P, Giovanelli L et al. A novel dense gas CO₂ supercritical fluid technology for the development of microparticulate delivery systems containing ketoprofen. Eur. J. Pharm. Biopharm.82(3),491–497 (2012).
  Medline CASGoogle Scholar
• 114  Lee SJ, Kim YH, Lee SH, Hahn M. Characterization of nano oxaliplatin prepared by novel fat employing supercritical nano system, the FESNS^®. Pharm. Dev. Technol.17(2),212–218 (2012).
  Medline CASGoogle Scholar
• 115  Kim YH, Lee SJ, Lee SH, Hahn M. Preclinical efficacy and safety assessment of nano-oxaliplatin oral formulation prepared by novel Fat Employing Supercritical Nano System, the FESNS^®. Pharm. Dev. Technol.17(6),677–686 (2012).▪ Description of oxaliplatin nanoparticles for the oral delivery, obtained by a novel process, based on lipid formulation and subsequent removal by sc-CO2. Preclinical pharmokinetic and efficacy is described.
  Medline CASGoogle Scholar
• 116  Soares da Silva M, Nobrega FL, Aguiar-Ricardo A, Cabrita EJ, Casimiro T. Development of molecularly imprinted co-polymeric devices for controlled delivery of flufenamic acid using supercritical fluid technology. J. Supercrit. Fluids58,150–157 (2011).
  CASGoogle Scholar
• 117  Soares da Silva M, Viveiros R, Morgado PI, Aguiar-Ricardo A, Correia IJ, Casimiro T. Development of 2-(dimethylamino)ethyl methacrylate-based molecular recognition devices for controlled drug delivery using supercritical fluid technology. Int. J. Pharm.416,61–68 (2011).
  Medline CASGoogle Scholar
• 118  Manion JR, Cape SP, McAdams DH, Rebits LG, Evans S, Sievers RE. Inhalable antibiotics manufactured through use of near-critical supercritical fluids. Aerosol Sci. Technol.46,403–410 (2012).
  CASGoogle Scholar
• 119  Overhoff KA, McConville JT, Yang W, Johnston KP, Peters JI, William III RO. Effect of stabilizer on the maximum degree and extent of supersaturation and oral absorption of tacrolimus made by ultra-rapid freezing. Pharm. Res.25(1),167–175 (2008).
  Medline CASGoogle Scholar
• 120  Sauceau M, Fages J, Common A, Nikitine C, Rodier E. New challenges in polymer foaming: a review of extrusion process assisted by supercritical carbon dioxide. Prog. Polym. Sci.36,749–766 (2011).▪ Compendium of extrusion processes relevant to pharmaceutical application. Gives an example of ‘hybrid technologies‘.
  CASGoogle Scholar
• 121  Kluge J, Mazzotti M. CO₂ high pressure homogenization: a solvent-free process for polymeric microspheres and drug-polymer composites. Int. J. Pharm.436,394–402 (2012).▪ Example of new, ‘hybrid process‘ based on SCFs combined with established technology.
  Medline CASGoogle Scholar
• 122  Lesoin L, Crampon C, Badens E. Development of a continuous dense gas process for the production of liposomes. J. Supercrit. Fluids60,51–62 (2011).
  CASGoogle Scholar
• 123  Chen AZ, Zhao Z, Wang SB, Li Y, Zhao C, Liu YG. A continuous RESS process to prepare PLA-PEG-PLA microparticles. J. Supercrit. Fluids59,92–97 (2011).
  CASGoogle Scholar
• 124  de Zordi N, Moneghini M, Kikic I et al. Applications of supercritical fluids to enhance the dissolution behaviors of Furosemide by generation of microparticles and solid dispersions. Eur. J. Pharm. Biopharm.81,131–141 (2012).
  Medline CASGoogle Scholar
• 125  Segale L, Mannina P, Giovannelli L et al. Celecoxib loaded microparticles by VarioSol^® technology. Presented at: 19th International Symposium on Microencapsulation. Pamplona, Spain, 9–11 September 2013.
  Google Scholar
• 201  Fries-land brands B.V.: WO097626 A1(2007).
  Google Scholar
• 202  Messer Italia S.p.A.: EP2298286A1 (2011).
  Google Scholar
• 203  Pierre Fabre Medicament.: US0270379A1(2007).
  Google Scholar
• 204  Ortho-McNeil Pharmaceutical, Inc.: US6627246B2 (2003).
  Google Scholar
• 205  Thar Pharmaceuticals Inc.: WO096144A1 (2008).
  Google Scholar
• 206  Xspray Microparticles ab.: WO072950A1 (2009).
  Google Scholar
• 301  Sitec-pharmabio. www.sitec-pharmabio.com/principle.php
  Google Scholar
• 302  Thompson C, Harris R, James J. Do you know SSO? PFQ. www.pharmaquality.com
  Google Scholar
• 303  Nanoparticles by supercritical fluid precipitation, new method for particle size reduction. www.micro-macinazione .com/news_2php
  Google Scholar
• 304  Supercritical solutions. www.supercriticalsolutions.com/en/technologies/formulplex
  Google Scholar
• 305  Xspray. www.xspray.com/process
  Google Scholar
• 306  Aktiv-dry. www.aktiv-dry.com/canbdprocess.html
  Google Scholar
• 307  Stanipharm. www.stanipharm.com/technologyapi.html
  Google Scholar
• 308  Natex. www.natex.at/download/PGSS_CPF.pdf
  Google Scholar
• 309  Nanotechnology: the next silver bullet? www.pharmtech.com/pharmtech/article/articleDetail.jsp?id=605695
  Google Scholar